2017 Japan Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
Complete report $8,800. DataPack (test volumes, sales forecasts, supplier shares) $5,700. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.
This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years. The report examines trends in the Japanese market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Japanese cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Japanese Market Overview
- Five-year test volume and sales projections.
- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing cancer diagnostic testing.
- Cancer statistics, etiology and recent developments in Japan.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines
Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major cancer diagnostic product suppliers by individual test.
- Five-year test volume and sales forecasts for major tumor markers by market segment, including:
º Hospitals
º Commercial/Private Laboratories
Instrumentation Review
- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
Technology Assessment
- Assessment of latest technologies and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies.
- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.
Competitive Strategies
- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
- The companies analyzed in the report include:
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zilla
Contains 590 pages and 95 tables
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers
2. Oncogenes
3. Polypeptide Growth Factors
4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing
VIII. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila
X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications
List Of Tables
Cancer Diagnostic ClassificationMajor Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: Japan, Total Cancer
Diagnostic Testing Volume and Sales Forecasts
By Market Segment
Japan, Estimated Cancer Death Rates
Japan, Laboratories Performing Cancer
Diagnostic Tests by Market Segment
Japan, Hospital Laboratories Performing
Cancer Diagnostic Tests by Bed Size
Japan, Commercial/Private Laboratories
Performing Cancer Diagnostic Tests
By Annual Test Volume
Japan, Total Cancer Diagnostic Testing Volume
Forecasts by Market Segment
Japan, All Market Segments Major Cancer
Diagnostic Test Volume Forecasts by Test
Japan, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecasts by Test
Japan, Commercial/Private Laboratories Major
Cancer Diagnostic Test Volume Forecasts
Japan, Total Cancer Diagnostic Sales
Forecasts by Market Segment
Japan, All Market Segments Major Cancer
Diagnostic Sales Forecasts by Test
Japan, Hospital Laboratories Major Cancer
Diagnostic Sales Forecasts by Test
Japan, Commercial/Private Laboratories Major
Cancer Diagnostic Sales Forecasts by Test
Japan, ACTH Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, AFP Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, CA 19-9 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, CA-125 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Calcitonin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Cathepsin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, CEA Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Chromogranin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecasts by Market
Segment
Japan, Cytokeratins Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Estrogen Receptor Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Ferritin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Gastrin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, HCG Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, Insulin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Interferons Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Interleukins Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, NSE Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, Nucleolar Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Occult Blood Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Oncogenes Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, PAP Smear Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Progesterone Receptor
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, PAP Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, PSA Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, S-100 Protein Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Serotonin Test Volume and
Diagnostics Sales Forecasts by Market Segment
Japan, Sialic Acid Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Japan, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecasts by Market Segment
Japan, TDT Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Thyroglobulin
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, TPA, Test Volume and Diagnostics
Sales Forecasts by Market Segment
Japan, Total Cancer Diagnostics
Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier
Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier
Global Liquid Biopsy Market: Analysis By Biomarkers (C-Tumor Cells, C-Tumor DNA, Vesicles), Cancer Type, By Product (Instruments, Reagents), By Region, By Country (2019 Edition): Opportunities and Forecast (2017-2024)
Executive According to research report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018. Over the recent years, Liquid Biopsy has been witnessing considerable growth
USD 1800 View ReportGlobal Cannabidiol (CBD) Market (2019 Edition): Analysis By Source (Hemp, Marijuana), Application (Pharmaceuticals, Cosmetics Industry, Others): Opportunities and Forecast (2017-2024)
Executive A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cannabidiol market.
USD 1200 View Report2023-2028 Japan Cancer Diagnostics Market
2023-2028 Japan Cancer Diagnostics Market--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers This unique report from provides information and analysis
USD 1850 View ReportJapan Cancer Diagnostics Marketual Tumor Markers
This unique report from provides information and analysis not available from any other published source, including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major
USD 1850 View ReportFill The Form For Sample Request